In the media
Company News
Paradromics CEO Matt Angle on the Neuralink Demo
Read more
Paradromics Raises $33 Million in Funding, Achieves Breakthrough Medical Device Designation from FDA
Read more
The Neurotech Revolution goes (back) to Washington!
Read more
Paradromics CEO Matt Angle at NANS 2023
Read more
The Neurotech Revolution goes to Washington!
Read more
Paradromics Announces Neurotech Track at Built with Biology 2022
Read more
Paradromics Announces NIH Award to Fund Translational and Early-Stage Clinical Research
Read more
Paradromics Raises $20MM in Seed Funding Led by Prime Movers Lab to Advance Brain Computer Interfaces
Read more
Paradromics Develops Precision Laser Surgical Tool that can be Used to Aid BCI Implantation
Read more
Paradromics Featured on Loup Ventures’ Neurotech podcast
Read more